INVA vs KRYS Stock Comparison
KRYS currently leads INVA in this stock comparison, with AIQ scores of 69 vs 67. The clearest difference is momentum, while INVA has the stronger value profile.
What is the main difference between INVA and KRYS?
KRYS leads the current stock comparison as Krystal Biotech, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Innoviva, Inc. vs Krystal Biotech, Inc.
KRYS leads
KRYS leads by 2 AIQ points, primarily on Momentum and Quality, but the lead has narrowed from 6 points over 30 sessions.
Fragile: 2 of 5 evidence groups support KRYS, its lead is narrowing, and its signal state is cleanly positive.
Innoviva, Inc.
Krystal Biotech, Inc.
The Algovestiq AIQ Score currently favors KRYS over INVA, 69 versus 67 as of Nov 15, 2026. KRYS's advantage is driven primarily by stronger momentum and quality, while INVA holds the stronger value profile. KRYS also shows the stronger technical structure relative to its 50-day moving average. 2 of 5 covered evidence groups favor KRYS today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 2 points. KRYS lead: Weakening — the AIQ differential moved from 6 to 2 points over 30 sessions.
Compare Innoviva, Inc. and Krystal Biotech, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare INVA and KRYS against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value92 vs 67INVA +25
- Momentum43 vs 58KRYS +15
- Quality76 vs 83KRYS +7
- Risk Resilience74 vs 69INVA +5
2 of 5 evidence groups favor KRYS. KRYS’s edge is concentrated in momentum and quality; INVA keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 7 active signals are unchanged.
Largest factor move: Momentum -1, not enough on its own to move the overall score.
New signals
- MACD Bullish Crossover — bullish, momentum, short horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
KRYS's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — INVA and KRYS both carry a full feed there.
The central trade-off
KRYS (Krystal Biotech, Inc.): the stronger current systematic profile, led by momentum and quality.
INVA (Innoviva, Inc.): the counter-case, on value, risk resilience, valuation.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
KRYSKRYS on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
KRYSKRYS on combined revenue and EPS growth.
Value
INVAINVA on the peer-relative Value factor, by 25 points.
Momentum
KRYSKRYS on the Momentum factor, by 15 points.
Lower downside
INVAINVA on Risk Resilience, by 5 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | INVA | KRYS | Note |
|---|---|---|---|
| Implied upside to target | — | +40.4% | Level |
| Target dispersion | — | +5.8% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 5 | 12 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
2 of 5 covered evidence groups favor KRYS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 67 vs 69 |
| Fundamentals | KRYS | revenue growth -11.3% vs 6.8%; EPS growth 9.6% vs 15.1%; TTM ROE -6.5% vs 4.4%; gross margin 73.9% vs 93.4%; operating margin 38.5% vs 48.4% |
| Valuation | INVA | Value 92 vs 67 |
| Technicals | KRYS | Price vs 50-day -8.1% vs -6.6%; vs 200-day -13.1% vs -1.4% |
| Risk Resilience | INVA | Risk Resilience 74 vs 69 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of INVA and KRYS and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 2 points. (argues the conclusion is provisional)
- Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on KRYS.
How the comparison changed
120 daily snapshots · May 27 – Nov 13KRYS lead: Weakening — the AIQ differential moved from 6 to 2 points over 30 sessions.
- Today
- KRYS +2
- 67 vs 69
- 7 sessions ago
- KRYS +3
- 69 vs 72
- 30 sessions ago
- KRYS +6
- 67 vs 73
- 90 sessions ago
- KRYS +7
- 65 vs 72
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 4 bearish / 1 neutral, conflicted
Only INVA
- Death Cross Active — bearish, trend, long horizon (5.74%)
- 52-Week Low Proximity — bearish, risk_regime, long horizon (1.6%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- Downtrend Structure Active — bearish, trend, long horizon
- Keltner Channel Breakdown — bearish, volatility, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-8.4%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
3 bullish / 0 bearish / 1 neutral
Only KRYS
- Golden Cross Active — bullish, trend, long horizon (5.51%)
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (3.65%)
- MACD Bullish Crossover — bullish, momentum, short horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
INVA is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.32%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.15%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1INVA closes the Momentum gap — currently 15 points behind, the largest single contributor to KRYS's edge.
- 2INVA's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3KRYS's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4The narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 2-point move would eliminate KRYS's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
KRYS leads on balance| Metric | INVA | KRYS |
|---|---|---|
| Revenue growth (YoY) | -11.3% | 6.8% |
| EPS growth (YoY) | 9.6% | 15.1% |
| Gross margin | 73.9% | 93.4% |
| Operating margin | 38.5% | 48.4% |
| Return on equity (TTM) | -6.5% | 4.4% |
| Debt to equity | 0.24 | 0.01 |
Performance
KRYS leads 6 of 6 windows| Metric | INVA | KRYS |
|---|---|---|
| 1 week (5 sessions) | -0.4% | 1.4% |
| 1 month (20 sessions) | -8.4% | -3.6% |
| 3 months (63 sessions) | -9.2% | -9.1% |
| 6 months (126 sessions) | -13.4% | -0.3% |
| Year to date | -4.8% | 23.8% |
| 1 year (252 sessions) | -14.6% | 50.3% |
Technicals
KRYS has the stronger structure| Metric | INVA | KRYS |
|---|---|---|
| RSI (14) | 33.1 | 43 |
| ADX (14) | 21.6 | 18.5 |
| Price vs 50-day | -8.1% | -6.6% |
| Price vs 200-day | -13.1% | -1.4% |
| Volatility (1M, annualized) | 38% | 47.8% |
Risk
INVA is the more resilient| Metric | INVA | KRYS |
|---|---|---|
| Beta | 0.31 | 0.74 |
| Sharpe ratio | -0.64 | 1.16 |
| Sortino ratio | -0.84 | 1.67 |
| Max drawdown | -22.2% | -21.8% |
| Current drawdown | -21.5% | -19.3% |
| Annualized volatility | 25.2% | 39.4% |
| Value at risk (95%) | -2.4% | -3.5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, INVA or KRYS?
On the Algovestiq AIQ Score, KRYS is the stronger of the two as of Nov 15, 2026, scoring 69 against INVA's 67. The edge comes from momentum and quality. INVA is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is INVA or KRYS the better buy right now?
KRYS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 2 points. Treat the lead as provisional.
Why does the AIQ Score favor KRYS over INVA?
The composite weights Quality, Value, Momentum and Risk Resilience. INVA leads Value by 25 points; KRYS leads Momentum by 15 points; KRYS leads Quality by 7 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, INVA or KRYS?
Analyst price targets imply not covered upside for INVA and +40.4% for KRYS. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, INVA or KRYS?
INVA is the better-valued of the two on the peer-relative Value factor. INVA on the peer-relative Value factor, by 25 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, INVA or KRYS?
KRYS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, INVA or KRYS?
KRYS on the Momentum factor, by 15 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, INVA or KRYS?
INVA is the more resilient of the two, so the other name carries the higher downside risk. INVA on Risk Resilience, by 5 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is INVA more profitable than KRYS?
KRYS leads on the comparable margin measures — gross margin 73.9% vs 93.4%; operating margin 38.5% vs 48.4%; ttm roe -6.5% vs 4.4%.
Is KRYS's lead over INVA getting stronger or weaker?
KRYS lead: Weakening — the AIQ differential moved from 6 to 2 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the INVA vs KRYS verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: INVA closes the Momentum gap — currently 15 points behind, the largest single contributor to KRYS's edge; INVA's Death Cross Active resolves — a bearish trend rule currently active against it; KRYS's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; the narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 2-point move would eliminate KRYS's advantage entirely.
What do the current signals say about INVA and KRYS?
INVA: 2 bullish / 4 bearish / 1 neutral, conflicted. KRYS: 3 bullish / 0 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on INVA is Death Cross Active (bearish, long horizon). On KRYS it is Golden Cross Active (bullish, long horizon).
Compare INVA and KRYS with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.